Pod Insights This Podcast Will Kill You Ep 177 Toxic Shock Syndrome: A shock to the system About this episode If you’ve ever read the little instructions pamphlet included in a box of tampons, you probably came across a paragraph calling attention to a condition called toxic shock syndrome (TSS). It describes the association between TSS and tampon use, symptoms of TSS, and guidance on how to reduce risk. This legally mandated warning label has formed an indelible link connecting tampons and TSS, and indeed, tampons form a large part of the story of TSS. But they are not the entire story. In this episode, we delve into that full story, examining what TSS actually is, the pathogens it’s associated with, and how it was first identified. If you’ve had TSS questions ever since you first heard of it in health class or on your box of tampons, this is the episode for you!
Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu
See omnystudio.com/listener https://omnystudio.com/listener for privacy information.
Transcript 14,785 words · 8 speakers
0:01 Speaker 00 This is Exactly Right.
0:06 Speaker 01 Hi, this is Mario Lopez from all Mario Lopez Daily Podcast. Buy smart, drive for less and trade for more. That's Toyota affordability. And it starts with a great deal on an all-wheel drive Camry, Corolla Cross, or a Corolla sedan with the latest features in tech. Or test drive a spacious Grand Highlander or adventure-ready RAV4. And with so many hybrid models available, you can enjoy longer trips without all the stops. While Toyota's legendary resale value means you could get more at traded. So get a great deal today and great value tomorrow. Shop toyota.com for deals and details. Toyota, let's go places.
0:42 Speaker 02 So, everyone on board?
0:43 Speaker 03 Yeah, I think so.
0:44 Speaker 02 You can't see it, but everyone in this room is nodding. They all agree the launch plan's perfect, but Julie has an idea how it can be even better. So she asks Copilot Cowork to help her overnight.
0:52 Speaker 04 Hey Copilot, gather the past three months of retail sales reports, surface key insights, and build a deck outlining a partner strategy by tomorrow morning.
1:04 Speaker 04 Morning team, I found a way to improve the plan. Check Slide 4.
1:08 Speaker 02 Get help with complex tasks with Copilot Cowork. Microsoft Copilot, work lives on.
1:12 Speaker 05 Along with your regular expenses like rent and student loans, tis also the season for gifts, travel, and those overpriced holiday-themed pop-up bars. Good thing Ally Bank is looking out for your money and you. With fee-free ATMs, no tricks, no hidden fine print, Ally meets you where money connects with life today. Analyzing your spending to help you spend smarter and save faster for next holiday season. Ally Bank, banking built for life today. Learn more by visiting ally.com. Use Allpoint or MoneyPass no-fee ATMs. Plus, we reimburse other ATM fees nationwide up to $10 per statement cycle. Surprise savings is a feature of Ally Bank's savings account. Ally Bank, member FDIC.
1:53 Speaker 06 Hey y'all, I'm Autumn. I'm a longtime listener and I am really excited to share my story. So when I was 18, I was hanging out with my boyfriend at the time at his house. And I was on the last day of my period, so I was wearing a size light tampon. It was about 10:00 PM and I was at that eight hour limit of my tampon. But he did not have a trash can in his bathroom. And I was also really scared of his mom and I did not want to venture to the kitchen trash. And so I figured that I would just change it when I got home. My midnight curfew came around. I went home, I changed my tampon, then I went to sleep. Woke up at 8:00 AM to change my tampon again. But now I was feeling a little bit woozy and I had this like itchy red palm rash.
2:39 Speaker 06 For a bit of context on this next part, I also have a condition called hereditary angioedema, which can often look and feel like an allergic reaction even though it's not. So I figured that I might have been having an HAE attack in my hands. And so I used a dose of my HAE medication, then I went back to sleep. You could equate it to maybe in a non-HAE patient, if you wake up, you feel some allergic discomfort and then you take a Benadryl or something.
3:06 Speaker 06 I woke up again at noon, as teenagers do on the weekend. And I just felt so nauseous and I was lightheaded and feverish and just overall real cruddy. I crawled down the stairs with a blanket and I laid on the couch to watch TV. And I kind of tracked up my symptoms to just random illness. And I figured that I'd be better tomorrow. I've had this bad track record ever since I was little of having these wild and just incredibly harsh bouts of strep throat. Often bad enough to go to the emergency room. And they would happen so suddenly and make me so sick that I could just be on death's doorstep today and then just be fine tomorrow.
3:50 Speaker 06 What if I had antibiotics, of course? And I've also struggled with these just seemingly endless infections of staph and strep bacteria on my skin, in my ears and in my eyes for just about my whole life. And me and my parents thought that this illness was just one of those situations. Or at least with Lou because it was January. And we really didn't think much of it until my hand rash was so bad that I could no longer hold my Gatorade. And it really wouldn't matter anyway because I could not keep my Gatorade down. And it got to the point where I vomited and I threw up down my front and on the couch. And I could not even like move to not throw up on myself.
4:34 Speaker 06 And that was when we went to the ER. It was about four PM when we got to the ER and then about seven PM, which was just eighteen hours after removing tampon zero. I was in the ICU with a blood pressure of fifty toes, a twenty-eight, a scorching fever, and then either a racing heart rate or a slowing heart rate, I really cannot remember. And then the gradual shutdown of my bone marrow, kidneys, and lungs. And it was obvious I was in septic shock, but no one could figure out why. Um, and then in my feverish haze, I remembered all of the warnings about toxic shock syndrome on tampon boxes and I told my doctors about what had happened with the tampon and trashcan.
5:18 Speaker 06 Toxic shock syndrome really wasn't on anyone's radar and nobody working in that hospital had ever actually seen toxic shock syndrome in person before. But that's what I ended up having. Five days of hospitalization, my first ever pelvic exam and catheters, awful, and enough lines and antibiotics to take down a horse, I was discharged. Um, thanks to early intervention, quick thinking, and then hospital staff intent on solving the mystery. I'm still alive today and I'm lucky to have not lost any limbs or organs due to tissue death. Um, the worst that I personally had in recovery was about a year of being immunocompromised and having to slough off all of the skin from my palms and soles and mucus membranes
6:03 Speaker 06 due to cell death, which is just about the grossest mental image you can muster, but I guess it's the price of being alive. And now that it's 10 years later, I'm really open about menstruation and what we can do to prevent TSS and who might be more susceptible to contracting TSS. And I love to talk about the need for free access to menstrual products and access disposal methods in all bathrooms, public and private. And as a person who now works with teens, I love putting my experience and advice to use in the hope that young people, even if they never have a run-in with TSS, will not treat menstruation as a taboo topic. Because I'm living proof on how treating things as taboo can just be a little bit deadly sometimes.
7:34 Speaker 04 Absolutely terrifying.
7:37 Speaker 03 Yeah, yeah. And to be the one who has to tell your doctors, "By the way..."
7:44 Speaker 04 I think it could be this.
7:45 Speaker 03 Could this be toxic shock?
7:47 Speaker 04 Oh my gosh. I mean, it just is like, yeah. And then especially because I feel like there's that sense of, I don't want to tell someone their job or be like, you know, I don't want to be like, "Oh yeah, I was on WebMD and this is what I think." But like, it's real, right? Like, you have to speak up and advocate and, oh.
8:07 Speaker 03 Hundred percent.
8:08 Speaker 04 Yeah.
8:08 Speaker 03 I'm a huge fan of people telling me what
8:10 Speaker 00 They found on WebMD. It's very helpful.
8:12 Speaker 03 I love that. I love that. Well, Autumn, thank you so much for sharing your story with us.
8:19 Speaker 00 Thank you, and we're so glad that you're okay.
8:21 Speaker 03 Yes, yes. Hi, I'm Erin Welsh.
8:25 Speaker 00 And I'm Erin Allman Updike.
8:26 Speaker 03 And this is This Podcast Will Kill You.
8:29 Speaker 00 Welcome to Toxic Shock.
8:31 Speaker 03 Toxic Shock. Yeah. Um, I'm, I, this is, I feel like one of those, I know we'll get so much more into the weeds, but I feel like this is one of those diseases where awareness around it is so much higher than the incidence of it, but it also, that means there's like, it's a double edged sword, right? Like, there's mean that there's more fear around it, but also, we can recognize it.
8:59 Speaker 00 Can we? Can we?
9:00 Speaker 03 Yeah, okay, that's fair. We're more likely to recognize it if it happens, yeah.
9:06 Speaker 00 I have, I have so many questions for you, Erin, about like, how we first saw this and like, all of the, I saw little bits and pieces of what happened in the late 70s, early 80s, and like, I, I just have so many questions still, and I'm, I'm really excited.
9:25 Speaker 03 Do you want me to go first?
9:26 Speaker 00 I kind of, but.
9:29 Speaker 03 We could, give it a go.
9:31 Speaker 00 That would be fun. On the fly.
9:34 Speaker 03 On the fly. Well, I guess before we get into literally any part of this, it's quarantine time. What are we drinking this week?
9:42 Speaker 00 We're drinking Shock Tactics.
9:48 Speaker 03 I could hear the pause, like, is it Shock Tactics?
9:50 Speaker 00 What was it again? We just went over this.
9:52 Speaker 03 We literally just talked about it. It's Shock Tactics.
9:55 Speaker 00 Shock Tactics.
9:56 Speaker 03 Yeah. And it's, it's, we're doing, honestly, we're doing like a make your own Quarantini if you want. But the standard recipe is a Placebarita version.
10:06 Speaker 00 So good.
10:07 Speaker 03 So good. It's sour cherry syrup, like sour cherries. They're the best.
10:12 Speaker 00 Yeah. Erin, before this was like, where am I gonna get sour cherries? Gosh, they're not in season on my tree yet. And I'm like, dude, they're frozen.
10:18 Speaker 03 Go to the.
10:20 Speaker 00 Frozen section.
10:23 Speaker 03 I do love, I mean, yeah, and I feel like my, I, my trees produce enough to make one cobbler type.
10:30 Speaker 00 They'll keep getting better. Before we moved, when we moved like from Illinois back out to California, the tree that year had the best year ever. And we had so many still in the freezer by the time we moved that I made a huge slab pie to take with us on the drive.
10:47 Speaker 03 I remember that.
10:48 Speaker 00 All that we ate. I think we gave some to you when we stopped in Colorado.
10:53 Speaker 03 Yeah. So sour cherries.
10:55 Speaker 00 Sour cherries.
10:56 Speaker 03 And then you can take the sour cherry syrup, add some club soda and a little bit of lime and it's like refreshing delight.
11:02 Speaker 00 So delicious.
11:03 Speaker 03 So delish. And we'll post the full recipe for that placebo Rita and then you can make your own Quarantini on our website, thispodcastwillkillyou.com and on all of our social media channels. If you're not following us, you should. You should also follow Exactly Right on YouTube so you can see the full video of this and a lot of our other newer episodes.
11:26 Speaker 00 Yeah, it's quite exciting stuff.
11:28 Speaker 03 It is, it is.
11:30 Speaker 00 Also, you can check out our website if you haven't done that already. It's called thispodcastwillkillyou.com and on it you can find such incredible things, including merch, including all of the sources from all of our episodes, links to Bloodmobile, who does the music, our Goodreads list, a bookshop.org affiliate account, our Patreon page, the list goes on.
11:54 Speaker 03 The list goes on.
11:55 Speaker 00 Check it out, thispodcastwillkillyou.com. If you haven't already rated, reviewed and subscribed, you can do that. We'd love it.
12:06 Speaker 03 Time for toxic shock syndrome.
12:10 Speaker 00 Syndrome. Okay.
12:12 Speaker 03 Okay. I'm gonna have you go first because I feel like it'll help me tell my story better.
12:16 Speaker 00 It's like the way we do things.
12:18 Speaker 03 It's the way we do it, yeah.
12:19 Speaker 00 Right after a quick break.
12:28 Speaker 04 Trade for more. That's Toyota affordability. And it starts with a great deal on an all-wheel-drive Camry, Corolla Cross, or a Corolla sedan with the latest features and tech. Or test drive a spacious Grand Highlander or adventure-ready RAV4. And with so many hybrid models available, you can enjoy longer trips without all the stops. While Toyota's legendary resale value means you could get more at trade-in, get a great deal today and a great value tomorrow. Shop toyota.com for deals and details. Toyota, let's go places.
13:03 Speaker 02 So, everyone on board?
13:04 Speaker 07 Yeah, I think so.
13:05 Speaker 02 You can't see it, but everyone in this room is nodding. They all agree the launch plan's perfect. But Julie has an idea how it can be even better. So she asked Copilot Cowork to help her overnight.
13:13 Speaker 00 Hey, Copilot. Gather the past three months of retail sales reports, surface key insights, and build a deck outlining a partner strategy by tomorrow morning.
13:25 Speaker 00 Morning, team. I found a way to improve the plan. Check Slide 4.
13:29 Speaker 02 Get help with complex tasks with Copilot Cowork. Microsoft Copilot. Work lives on.
13:46 Speaker 00 Toxic shock syndrome, or TSS, is a disease. It's called a syndrome because it was like just a collection of signs and symptoms before we knew what caused it. But now we know exactly what causes it. And it's caused by a toxin, or rather, a group of toxins that are produced by two old-time friends of the podcast.
14:07 Speaker 00 That is Staphylococcus aureus or Streptococcus pyogenes, or Group A strep.
14:13 Speaker 03 Okay.
14:14 Speaker 00 So Erin.
14:15 Speaker 03 I was like, are you have a question?
14:17 Speaker 00 Already off the bat. Um, I thought about, as I was putting this together, I was like, I should probably check in with Erin and see if she's doing this. History of like STAFF TSS or strep TSS, but then I was like, I don't care. I'm gonna do both.
14:30 Speaker 03 Great.
14:31 Speaker 00 Okay, great.
14:32 Speaker 03 I think I'm doing STAFF TSS.
14:34 Speaker 00 That's what I assumed because that is more related to like menstrual TSS, which we'll talk in a lot of detail about. But we're gonna talk about both. So there's STAFF-associated toxic shock and then there's strep-associated toxic shock.
14:46 Speaker 03 Okay, real quick, this is just a minor question.
14:48 Speaker 00 Uh huh, give it to me.
14:49 Speaker 03 It should, yeah. Toxic shock, it's no longer called toxic shock syndrome because it's not a syndrome.
14:55 Speaker 00 No, it totally is still called toxic shock syndrome. Yeah, yeah.
14:58 Speaker 03 Okay.
14:59 Speaker 00 Yeah. It's just that's how it got its name initially.
15:02 Speaker 03 Yeah.
15:03 Speaker 00 But it's still called that.
15:05 Speaker 03 Okay.
15:05 Speaker 00 Yeah.
15:06 Speaker 03 Well, I thought because you said that because it's, it's, we know what causes it. We know all of this, that it was initially called a syndrome and now.
15:13 Speaker 00 No, it's just that like some people who are into semantics are like, it's not that accurate anymore, but like it's still.
15:18 Speaker 03 Oh, right. Okay, okay, okay. There are more important things to worry about than like.
15:22 Speaker 00 Aren't there?
15:23 Speaker 03 Yeah, I think so. Like toxic shock.
15:27 Speaker 00 Toxic shock, syndrome, disease, whatever. So toxic shock, it's caused by toxins released by STAFF or strep. And these are both gram-positive, really cute little ball-shaped bacteria. And the most famous of the two is STAFF TSS. And that's because that is the one that is more strongly associated with menstrual and tampons, with menstruation and tampons.
15:58 Speaker 03 Yeah, you just mean like infamy or do you mean like sheer number of cases?
16:02 Speaker 00 I mean infamy, not sheer number of cases, as we'll get into later.
16:06 Speaker 03 Okay.
16:07 Speaker 00 But we're gonna kind of talk about all of these because the mechanism is really quite similar in all of these instances, whether it's menstrual-associated toxic shock or non-menstrual toxic shock, whether it's STAFF or strep that produce that toxin. There are some differences in like the kinds of symptoms that we see, whether it's STAFF or strep, but I'm gonna kind of just focus on the similarities. Okay?
16:30 Speaker 03 Yeah.
16:31 Speaker 00 So in any case, like I said, it really is a kind of clinical definition, how we find toxic shock. And so it's a set of signs and symptoms that we're looking for. There's not one diagnostic test that says you have toxic shock.
16:44 Speaker 03 Right.
16:45 Speaker 00 So let's go over what those symptoms kind of look like, how it manifests, because that's how we get to how we diagnose it, right? So in toxic shock, people generally start with a fever. And this might not be the first symptom, but it is a very, very common and important symptom. And that fever tends to be quite high. So we're looking at like 102 Fahrenheit or higher. That's 38.9 Celsius or higher.
17:09 Speaker 03 Okay.
17:10 Speaker 00 The shock part of it means that there's also hypotension or low blood pressure.
17:16 Speaker 00 Because that's part of shock.
17:17 Speaker 03 Why?
17:19 Speaker 00 Why does that happen? Oh, we'll get there.
17:21 Speaker 03 Okay, okay, okay. We're just going through the symptoms.
17:23 Speaker 00 We're going through the symptoms. This is how we know signs and symptoms.
17:25 Speaker 03 Yeah.
17:26 Speaker 00 You also, especially in the case of staphylococcal toxic shock, will see a rash. And this tends to be like a diffuse, kind of splotchy, red rash. Sometimes it's described as like sunburn-like. And then we'll also see evidence, either laboratory evidence, like when we're looking at your lab results, or symptom evidence of multi-organ involvement on the way towards organ failure. And so this could be involvement of your kidneys. It could be your liver. It could be your musculoskeletal system, which we might see with like pain or with laboratory findings. It can be neurologic manifestations. It can be literally any organ system that's affected.
18:10 Speaker 00 And usually to meet the criteria, you have to have at least two organ systems, like evidence of damage in at least two organ systems.
18:17 Speaker 03 Okay.
18:18 Speaker 00 When it's streptococcal toxic shock, almost always you will find some kind of initial infection, some kind of initial invasive infection, like a necrotizing fasciitis. Or a cellulitis.
18:36 Speaker 03 Okay.
18:36 Speaker 00 Or evidence of a bloodstream infection. So growing this streptococcal bacteria in your bloodstream.
18:42 Speaker 03 Yeah.
18:43 Speaker 00 With staph, you might not, very often, you do not see an initial infection like a cellulitis or something that kind of precipitates this. And with staph, only about 5% of blood cultures are positive for staph aureus in toxic shock, compared to like 60 to 80% of blood cultures being positive in streptococcal toxic shock.
19:07 Speaker 03 Okay.
19:08 Speaker 00 Does that make sense?
19:09 Speaker 03 Yes.
19:10 Speaker 00 Yeah.
19:10 Speaker 03 A couple of questions.
19:11 Speaker 00 Okay, go.
19:12 Speaker 03 Sorry.
19:14 Speaker 03 Number one timeline of these, of these signs and symptoms, like, does it start with a fever? Like, at, at what point does it go from, you know, not so great, feeling bad rash to shock multi-organ involvement?
19:28 Speaker 00 It's such a good question. I don't, there's not a good, I don't have a good number for you.
19:32 Speaker 03 Okay.
19:33 Speaker 00 In part because it's going to differ, you know, if we're talking streptococcal versus staphylococcal, right? Like, if it's an infection, how quickly does it go downhill? It really depends on the infection. With streptococcal toxic shock, which very often might not have, you know, evidence of an infection necessarily. Because there's not necessarily evidence of infection, we don't have this, like, traditional incubation period where you're like, oh, might have this amount of time, or how long does it take?
20:00 Speaker 03 Right.
20:01 Speaker 00 But what I will say is that once this has started to develop, so once you see this evidence of like fever and the blood pressure starting to go down, this process can happen very rapidly. So you can see signs of organ damage and rapidly worsening clinical status within like 24 to 48 hours.
20:18 Speaker 03 Okay.
20:19 Speaker 00 Yeah.
20:20 Speaker 03 That's very fast and terrifying. Another question then, so related to the blood cultures.
20:27 Speaker 00 Yeah.
20:27 Speaker 03 Can you also screen for the toxins themselves? Like, is that the way that people look for this?
20:34 Speaker 00 You, so you could, if you, if you had the capability to do that, so if you had like the right PCR-based testing or whatever it is, you might, you might, A, not have that capacity, or you might not think to, because if you can't, like, if you haven't detected any bacteria, then how do you know what toxins to look for and that kind of a thing? So yeah, so I don't have a great answer for that. But what is really important, because we don't have a great test for it, is that we do have to show that there's no other infection, right? So part of the definition, especially for staphylococcal toxic shock, is that you have to show that there's no Rocky Mountain spotted fever. There's no leptospirosis.
21:18 Speaker 00 It's not actually measles. It's not meningitis. Like, you have to rule out all these other things.
21:24 Speaker 03 Yeah.
21:25 Speaker 00 Before you can say that this is toxic shock. But here's where it gets even more interesting, especially when we talk later about the epidemiology. Part of the case definitions in the literature and per the CDC for staphylococcal toxic shock is that one to two weeks after this initial presentation, people develop a new kind of rash where the palms and soles of your hands and feet just kind of, the skin rubs off. It's called a desquamating rash.
21:57 Speaker 03 Yeah.
21:58 Speaker 00 But that means that that definition can only be met retrospectively, right?
22:05 Speaker 03 Right.
22:05 Speaker 00 And so it's a complicating factor and probably leads to part of why we likely see an under-reporting of toxic shock. Because these are like, kind of messy criteria, right? And a lot of other things could potentially fit into this. And so we don't have great numbers. That's a spoiler alert for, for the future of this episode.
22:25 Speaker 03 Yeah. Hey, shocking. Wow, I really didn't mean to do that. Okay, so staph aureus is often a, like a part of our biome. Like, it's part of our microbiome.
22:39 Speaker 00 It absolutely is.
22:40 Speaker 03 Is streptiogenes.
22:41 Speaker 00 Oh, it can be, definitely.
22:43 Speaker 03 It can be, okay.
22:43 Speaker 00 It can be, yeah. In like, your throat or your nose or something like that, it can be.
22:47 Speaker 03 Throat and your nose, interesting.
22:48 Speaker 00 But staph is definitely like, it is our friend. Staph lives on probably almost all of us.
22:53 Speaker 03 Yeah.
22:53 Speaker 00 So how does this actually happen? How do you get from like, I don't know, staph just living on you to toxic shock? Well, let me tell you. It can happen either from an infection, right? Often, we see toxic shock. Like I said, with streptococcus, it's necrotizing fasciitis or some kind of infection that leads to an invasive infection. With staph, it's often seen in the post-operative setting. So it could be like a wound or an incision after an operation because staph is just everywhere if it happens to get in there and multiply.
23:31 Speaker 00 Or if you happen to be colonized, let's say in the vagina, and then you have an overgrowth of this particular strain of these bacteria that produced a particular kind of toxin. And there's multiple different versions of this toxin. The one that is, again, most infamous, and you'll talk about later, Erin. Well, I don't know if you'll talk about the toxin, but the most infamous cause of toxic shock is caused by a toxin called T S S T one, Toxic Shock Syndrome toxin.
24:07 Speaker 03 That's straightforward.
24:09 Speaker 00 But all of these toxins that cause toxic shock are called superantigens. And we talked about this idea of a superantigen actually in our scarlet fever episode, which you may remember scarlet fever is caused by streptiogenes.
24:24 Speaker 03 Right, right.
24:26 Speaker 00 A specific strain of streptiogenes. So superantigens are proteins. These toxins are proteins that bacteria can make and excrete that, when they get into our body, trigger an overwhelming immune response. This idea of like a cytokine storm that we've talked about here and there on the podcast. And this overwhelming immune response itself, in combination with direct damage that these toxins are causing, just like ripping through our cells, is what ends up causing all of the symptoms that we see in association with toxic shock.
25:07 Speaker 00 The fevers, leaky blood vessels that lead to hypotension, dropping blood pressure, all of the damage that we see to our organs, whether that's damage directly to the tissues of the organs themselves or damage to the blood vessels that are feeding those organs, right? And all of this is what results in the damage that we see and the shock part of Toxic Shock Syndrome.
25:30 Speaker 03 Okay, and so it's not really about, okay, like, the toxin itself is not acting in this way. It's our immune system responding to this toxin. And so it doesn't have to be like, like, I'm just trying to figure out why this toxin exists. And I'm assuming it's like, is it competition with other microbes? Like, what's, what's going on? Do you know the answer?
25:55 Speaker 00 I don't, but it's such an interesting question, Erin. Yeah. I didn't look into that, like, the evolutionary history or anything of these types of toxins.
26:03 Speaker 03 Right.
26:04 Speaker 00 But it's really, really, really weird. I can't, do you want a little more detail?
26:07 Speaker 03 Yeah, I do. I would love a little more detail. Thank you.
26:10 Speaker 00 It's really, really interesting and weird how these toxins work. And, and the question of like, why do they exist? Ah, it's so, so interesting because here's what they basically do.
26:23 Speaker 00 We're going to step back a minute to talk about like, what is a typical immune response? Right? We get exposed to various toxins or antigens, like, all the time. Right? And in our typical immune response, we have these cells that, these cells that go around and find these antigens, right? Antigen presenting cells. They usually process them in some way. And I, we've talked a lot about our immune response on this podcast before, and we've kind of glossed over this part because it's just what they do. Right? They kind of take them in and they like, break them up and they're like, beep it a bop, let's find the part. And then they present those antigens to our T cells.
26:58 Speaker 03 Yes.
26:59 Speaker 00 Who then decide what kind of response to engage in. Do we do inflammatory stuff? Do we do antibody stuff? Whatever. Okay? So these antigen presenting cells are like a mediator. They are the ones who take all the antigens and they decide, like, which parts do we show to T cells? Like, how are we gonna start this process? Right?
27:20 Speaker 03 They're making these decisions.
27:22 Speaker 00 Exactly. They're organizing, sorting through things.
27:24 Speaker 03 Yeah.
27:25 Speaker 00 What super antigens are doing is bypassing this process. Super antigens, they themselves go directly to the T cells, grab a hold of these T cells, and then grab a hold of these antigen presenting cells and bind them together, like, bridge them. And they're like, let's get this party started. And that causes this massive immune response. And I was trying, Erin, because you're so So good at analogies.
27:51 Speaker 03 No.
27:54 Speaker 03 The number of times that we've been like, this analogy doesn't need to exist. This analogy has been taken too far.
27:59 Speaker 00 I know, but I love that. Okay, so I tried so hard to come up with analogies for this. Here's the best one that I could come up with. It's so bad. Okay, super antigens are like the loudest guy at the party. Like the one that you didn't really mean to invite or like didn't actually want to come in.
28:19 Speaker 03 Yeah.
28:19 Speaker 00 Made it straight to the DJ booth somehow.
28:22 Speaker 03 Oh, no.
28:22 Speaker 00 And then like opened all the doors and everyone's just rushing in. The bouncers didn't catch him. Something like, that's my analogy.
28:29 Speaker 03 Oh, my God. Okay, so it's like, it's like those high school parties. You know, where it's like, oh, just a few of us. And then unbeknownst to the, the host.
28:36 Speaker 00 The host.
28:36 Speaker 03 Friends have invited all of their.
28:38 Speaker 00 The whole school and all of the other schools.
28:41 Speaker 03 And yeah, and they're just run through the doors. Okay.
28:43 Speaker 00 They just run through the doors.
28:44 Speaker 03 Wow.
28:44 Speaker 00 So it's this overwhelming, way too expansive immune response. Do you love that?
28:50 Speaker 03 I'm stressed about it because those, those scenes in movies always stress me out. Cause I'm like, you're gonna hurt the house. Like, what about this? Who's spilling on the carpet?
29:00 Speaker 00 Like every teen movie you've ever seen.
29:01 Speaker 03 Yes. I was not cool in high school, if you can imagine.
29:06 Speaker 00 I think I went to my first high school party when I was definitely in college, so.
29:11 Speaker 03 I was one being like, are you using coasters? Do you need a coaster? I've got, I've got a little basket of them.
29:18 Speaker 03 Wasn't even my house, but I was just like, you gotta respect the wood. Yeah.
29:25 Speaker 03 Anyway, yeah, so I can see why super antigens would be a real pain.
29:29 Speaker 00 A real pain, right? And to give you more of like a numeric sense of this, to see how much these super antigens are overdoing it.
29:39 Speaker 00 Regular antigens? Like just your typical ones activate about point zero one percent of our T cells on average. Okay.
29:47 Speaker 03 Point zero one percent.
29:48 Speaker 00 A very small proportion of our T cells are being activated by any given antigen that we're exposed to. Super antigens are activating five to thirty percent of our T cells. Ba da.
29:59 Speaker 03 Okay, where, what, um, so scarlet fever, another super antigen. What about, what makes a super antigen, a super anti, like, obviously, we know the characteristics of it.
30:12 Speaker 00 Right.
30:12 Speaker 03 But like, what, is there a range, is there a spectrum of of antigenicity from not very, I mean, obviously, but to super antigen, why, why, I guess, is just the question.
30:26 Speaker 00 That's the question, Erin. It's a great question. Well formulated.
30:30 Speaker 03 Thank you so much.
30:33 Speaker 00 Yeah. I don't know, though.
30:38 Speaker 03 Fascinating. Okay.
30:39 Speaker 00 Isn't it?
30:40 Speaker 03 Yeah.
30:41 Speaker 00 So, yeah, so, I mean, that, that is toxic shock, and that is, you know, how it happens. And what, like, what is going on in our bodies in terms of the pathophysiology?
30:50 Speaker 03 Okay, so question about the two different strep and staph.
30:55 Speaker 00 Give it to me.
30:55 Speaker 03 Toxic shock. Is there a difference in case fatality rate?
30:59 Speaker 00 Absolutely.
31:00 Speaker 03 A difference in treatment?
31:02 Speaker 00 Yes.
31:02 Speaker 03 And management? And is there a difference in, like, susceptibility, again, in the future to it?
31:10 Speaker 00 Such fun question, Erin. Case fatality, definitely.
31:13 Speaker 03 Okay.
31:14 Speaker 00 Let me scroll in my notes. Case fatality rates for streptococcal toxic shock are very depressing, anywhere from like thirty to sixty percent.
31:28 Speaker 03 Okay.
31:28 Speaker 00 So very, very, very deadly.
31:30 Speaker 03 Yeah.
31:31 Speaker 00 And remember that streptococcal toxic shock is very, almost always associated with some kind of invasive infection.
31:40 Speaker 03 Right.
31:40 Speaker 00 So the treatment requires that you identify what that infection is. You try and get, like, source control if you can, so that means if there's, like, a necrotizing fasciitis, you have to debrid all of that dead tissue that is completely overrun with bacteria. And then you need to also treat the toxic shock, which I'll talk about in just a second. With staphylococcal toxic shock.
32:03 Speaker 00 The case fatality rates really can vary. And most of what I saw estimated that the majority of staphylococcal toxic shock cases are actually not menstrual. And we'll talk a little bit more about what that means. But they're actually more likely to be something like a wound related or a post-operative infection, something like 60%
32:25 Speaker 03 Okay.
32:25 Speaker 00 of staphylococcal toxic shock is from that rather than from menstrual sources. The fatality rates, I've seen a real range, anywhere between like eight and 20%. But most places also say that menstrual toxic shock is very rare to cause fatalities. And I don't know if that's just based on like current data or if that has been true historically as well, but that is what all of the literature that I read suggested.
32:54 Speaker 03 Interesting.
32:55 Speaker 00 Yes.
32:55 Speaker 03 Okay.
32:56 Speaker 00 It's very interesting. And is that because of, you know, like demographics? Because people who are getting maybe wound infections or operative infections are maybe like older or have more comorbidities or something like that?
33:08 Speaker 03 Compromise in some way.
33:09 Speaker 00 Or is it because that they also have this infection that you're dealing with?
33:13 Speaker 03 Right.
33:13 Speaker 00 Where most of the time with menstrual-associated toxic shock, there's no infection. So like 10 to 40% of menstruating people just have staph aureus in their vagina at any given time.
33:27 Speaker 03 Right.
33:27 Speaker 00 And the amount and quantity of different bacteria really changes during your menstrual cycle because of changes in the pH and things like that with menstrual blood and all that kind of stuff. And I said that it's only certain strains of these bacteria that produce this toxin. It's estimated that like 18 to 25% of strains of staph aureus across the board have the gene that encodes for this toxin. But even then, not all of those bacteria, even if they have that gene, are going to make the toxin because the environment also has to be right to induce them to actually make that toxin.
34:07 Speaker 03 Right. Interesting. Okay, so they have, it's not like these are just going around producing this toxin all of the time.
34:13 Speaker 00 No, not at all.
34:15 Speaker 03 It's dependent upon, and do we know what those environmental conditions are?
34:18 Speaker 00 We do, Erin. So glad you asked. So one of the things that we know is that it has to be an environment that is aerobic. They need oxygen. Staph aureus can grow with or without oxygen. But in order to produce this toxin in strains that can produce this toxin, they need the presence of oxygen.
34:39 Speaker 03 Okay.
34:40 Speaker 00 They also need like a warm but not too warm of temperature. They need like a certain pH range, not too high, not too low, things like that.
34:49 Speaker 00 And so, conditions have to be right for this bacteria to grow to a degree. And then to have the toxin, like the gene to make this toxin. And then to actually be induced to produce this toxin.
35:07 Speaker 03 Okay.
35:07 Speaker 00 Before somebody can even be exposed to potentially get toxic shock. And then you asked Erin, what about recurrent infections? This is such a good question because we're talking about an antigen and we usually make antibodies against antigens, right?
35:23 Speaker 03 Uh huh.
35:24 Speaker 00 Something like 80% of people have antibodies against these types of super antigens, especially when we're looking at the common one, T S S T one.
35:36 Speaker 00 Most people, like if you just surveyed a random group of people, have antibodies against this. Meaning that we're probably exposed to it at low levels and we're making antibodies against it.
35:46 Speaker 03 Okay.
35:47 Speaker 00 When we are thinking about who is it that ends up getting toxic shock, it is not a simple question.
35:53 Speaker 03 No.
35:53 Speaker 00 It is not like, oh, if you have a tampon in for too long. No. It is not anything near straightforward. Because there has to be the correct environment. One to 5% of people are thought to be colonized in the vagina with strains that can potentially produce this toxin.
36:13 Speaker 03 Okay.
36:13 Speaker 00 So 1 to 5% of people, we're talking about menstrual.
36:16 Speaker 03 Yeah.
36:16 Speaker 00 Focus on that for a second. Then you have to have an environment that is conducive. So you need to have enough oxygen. Now menstrual blood, blood contains oxygen.
36:28 Speaker 03 Mm hmm.
36:28 Speaker 00 So that can increase the oxygenation level of the environment and potentially help to shift those bacteria into producing the toxin.
36:37 Speaker 03 Yep.
36:38 Speaker 00 Tampons, as you'll talk about Erin, are strongly associated with especially the emergence of toxic shock as a syndrome.
36:45 Speaker 03 Mm hmm.
36:46 Speaker 00 And the thought on part of the reason why is that because these are absorbent materials, they contain oxygen.
36:56 Speaker 03 It's.
36:56 Speaker 00 Are you gonna talk?
36:57 Speaker 03 I mean, I'll just talk a little bit about it, but like, it's just like, this is the part where I still have found so much disagreement, not even disagreement, but lack of clarity on.
37:08 Speaker 00 Yes.
37:09 Speaker 03 And these are the characteristics. This is how step, you know, step one, step two, step three. Is it that, is it the tampons? Is it the blood? Is it like, is it a micro abrasions? Is it leaving tampons in too long? Is it taking them out? It's like all of these different questions.
37:26 Speaker 00 And Erin, it's all of these different things. And that's the point.
37:28 Speaker 03 Yeah.
37:29 Speaker 00 It's not one thing. It is not one thing. It is an individual risk factor. Are you colonized with this? It's an individual risk factor. Do you already have enough neutralizing antibodies or not? Do you have some kind of immunocompromised where you're not producing as many antibodies for some reason or another? Have you been exposed to this at lower levels and developed antibodies or not? What is the oxygenation level in your vagina and in your menstrual blood? What kinds of, like, how heavy is your flow? Are there micro abrasions that make it easier for either bacteria or the toxin to get into, like, pass through that mucous membrane, get into your bloodstream?
38:05 Speaker 03 Right.
38:06 Speaker 00 How much oxygen is being contained in the tampon versus in the menstrual cup? Because by the way, there have been at least two cases reported from menstrual cup use. So I feel like especially when we're thinking about menstrual toxic shock, what I took away from all of this, and we'll talk more about it in the like, looking at the numbers of all of this and how rare this disease is, is that.
38:31 Speaker 00 We need a lot more research when it comes to reproductive health and like the best menstrual products and all of this stuff, but we cannot weaponize tampons, saying that like tampons are the problem here.
38:42 Speaker 03 Ah, well, yeah, it's, it's complicated.
38:46 Speaker 00 It's complicated.
38:47 Speaker 03 Yeah.
38:48 Speaker 00 It's complicated.
38:49 Speaker 03 Yeah.
38:49 Speaker 00 But it is not like, the tampons are not introducing any bacteria that we know of. These are bacteria that are already present in the environment.
38:56 Speaker 03 Mm-hmm.
38:56 Speaker 00 Uh, and we have a lot of data that, like, we do not have nearly as much data as I feel like we should, but I think it is in part because of how rare this disease is.
39:09 Speaker 03 Mm-hmm.
39:09 Speaker 00 And how many complicated factors there are that go into this, right? Like, it is, it is just not as straightforward. And so I feel like the takeaway that I got is not like, this is evil, this is good, but like,
39:22 Speaker 03 No.
39:23 Speaker 00 we need more information on this and we also can't, because one of the papers I read suggested as a way to prevent it, to not use feminine hygiene products, Erin. And I was like, sorry, what?
39:36 Speaker 03 It, I mean, that is not a very well-thought-out solution.
39:44 Speaker 00 No.
39:45 Speaker 03 To put it mildly.
39:46 Speaker 00 To put it mildly, okay? But yes. I feel like I got a little bit off track and probably out of order there.
39:54 Speaker 03 No, no. Okay, so, but to, maybe get us back on track.
39:59 Speaker 00 Yeah.
39:59 Speaker 03 Treatment.
40:00 Speaker 00 Treatment.
40:00 Speaker 03 What do we do?
40:01 Speaker 00 Yeah, so I mentioned source control, that's going to be important, so that means taking care of any infection that we know of. If it is a menstrual toxic shock and there is a menstrual device in place, like a cup or a tampon or whatever, removing that. And then, the most important thing is using antibiotics that are going to have ability to prevent more toxin production. And so that usually means clindamycin, because that helps block protein synthesis, and so it helps block production of the toxin. But then it's also a lot of like supportive care, right? It's fluid resuscitation, it's blood pressure support. It's broad spectrum antibiotics because a lot of times you can't, you don't know what it is yet. All of this takes a long time to figure out.
40:41 Speaker 03 You gotta act fast. Yeah.
40:42 Speaker 00 Interestingly, there's some evidence for the use of IVIG.
40:46 Speaker 03 Okay.
40:47 Speaker 00 Uh, which is like, uh, IV combined immunoglobulin from like a bunch of different sources. It's basically pooled antibodies and giving people really high doses of a ton of random antibodies. The thought is that that will help like bind to this toxin and inactivate it. There's not super strong data for it, but it's in part because of the difficulties of doing these kinds of clinical trials on very small sample sizes. But there's some data that it might be helpful, especially for streptococcal more than staphylococcal, just because that's the data that we have.
41:15 Speaker 03 Okay. Yeah.
41:17 Speaker 00 And that's mostly it, Erin.
41:20 Speaker 03 Okay.
41:21 Speaker 00 Yeah. Uh, and you asked if you can get it again, you can, uh, which makes it even that much more interesting because you can, you can get it again, even under different conditions. People who have had menstrual toxic shock, especially in the context of tampon use. There has been reports that people have had recurrences without tampon use.
41:42 Speaker 00 Which again, points to the fact that it's not just the tampons. It's a much more complicated thing than that.
41:48 Speaker 03 Right.
41:49 Speaker 00 But yes.
41:50 Speaker 03 Yeah. I think I have more questions, but I'm gonna, they're just gonna have to come to me like, I just, there's so much that.
41:57 Speaker 00 I know.
41:57 Speaker 03 Yeah.
41:58 Speaker 00 Well, I have questions too, Erin, because like, obviously a lot of the papers that I read couldn't not say like, well, we first found out about this.
42:05 Speaker 03 I mean, I am literally just gonna be talking about tampons, so.
42:09 Speaker 00 I cannot wait to talk about tampons.
42:12 Speaker 03 I can't wait to tell you. Let's take a quick break.
42:17 Speaker 07 This is Jason Timp from Hoops Tonight with Jason Timp. Buy smart, drive for less and trade for more. That's Toyota affordability. And it starts with a great deal on an off-road ready Tacoma or half ton Tundra. Two of Toyota's longest lasting trucks, combining power for work, tech for adventures and style in between. Built on a reputation for quality and reliability, Toyota trucks are known for holding their value, which can mean big savings when it's time for your next Toyota. So get a great deal today and great value tomorrow. Shop toyota.com for more. Toyota, let's go places.
42:48 Speaker 00 Morning Carmen. Good morning. Quick questions. Just one second.
42:51 Speaker 02 Sorry. Carmen's worked at this office for 20 years. She knows everything, which is why Carmen has to help with, well, everything.
42:58 Speaker 05 Hey Carmen, what did Faye pitch in 2023? Who owns the Nordic account? Oh, uh, where's the printer?
43:03 Speaker 01 Carmen's revenue report is due in five minutes, so she shows them work IQ. Hey, Copilot, who owns the Nordic account? And what did we pitch them in 2023? Get the context you need with Microsoft Copilot. Work lives on.
43:34 Speaker 03 Erin, do you remember when you first learned about toxic shock syndrome?
43:39 Speaker 00 Oh, good question. No.
43:42 Speaker 03 No?
43:43 Speaker 00 I just feel like in my memory, and this is not, I'm sure not correct, but I just feel like I have always known about.
43:50 Speaker 03 You were born with the knowledge.
43:52 Speaker 00 No, no, no. Like, it was like tampons, toxic shock. Like, that was a connection that existed in my memory from the first time that I can remember using a tampon. And I don't know if I actually learned it that first time, or if it was like later knowledge.
44:06 Speaker 03 I mean, that's similar to me. Like, I don't know if it was in like health class or something like that, but I.
44:13 Speaker 00 I'm sure it wasn't in health class. For me.
44:15 Speaker 03 Probably, yeah.
44:17 Speaker 00 I mean, just speaking personally.
44:18 Speaker 03 Yeah. I mean, I, again, yeah, I, I don't know, but I do, I do have this, this memory of being in my house in Northern Kentucky, like getting my first period and reading that little instruction pamphlet that came in the box.
44:33 Speaker 00 In the tampons.
44:34 Speaker 03 Yeah. And like in one little corner was this dire warning about this deadly disease called toxic shock syndrome that you could get from using tampons.
44:42 Speaker 00 Yeah, uh huh.
44:43 Speaker 03 And I feel like that made such an indelible mark on me for years after I was like worried, but also a little confused. Like, what was it using it to? Again, like all these questions. Was it, am I going to get it because I used a tampon for too long or because I took it out too soon? Like, what is going to give me toxic shock?
45:03 Speaker 00 Yeah.
45:04 Speaker 03 Yeah. Should I be using tampons at all? Is that going to help me? Like, right? Clearly, I think that the takeaway that I had was if I got toxic shock, it was my fault because I didn't know the answers and I wasn't sure where to get them or who to ask.
45:21 Speaker 00 Oh, my gosh, Erin, that's so heartbreaking to imagine little like baby Erin being like, well, if I die, it's on me.
45:27 Speaker 03 I mean, it was just like you're if you use because it's like use the right amount, use the right absorbency.
45:34 Speaker 00 How the heck are you supposed to know, especially when you're 16 years old?
45:37 Speaker 03 When you're 16 years old, if you have irregular periods, like there are so many different things where it's like, but I felt like, okay, well, this is just like part of what it means to be a woman, right? Like I have my period now, I have to deal with toxic shock.
45:50 Speaker 03 I mean, it wasn't like something that like
45:52 Speaker 00 This is my lot in life, as we learned.
45:54 Speaker 03 Right. But I just sort of felt like, okay, like this is, this is the knowledge. This is part of it.
45:58 Speaker 00 Okay.
45:59 Speaker 03 And I feel like after reading for this episode, it seems to me that this, the history of toxic shock syndrome reveals how the silence and the shame surrounding menstruation and menstrual products, it presented a challenge, both in identifying the source of this deadly infection, as well as raising awareness at a time when words like tampon, menstruation, and period were still taboo words.
46:26 Speaker 00 I cannot.
46:29 Speaker 03 And I think it also demonstrates how the blame has been shifted away from tampon manufacturers who did not properly evaluate their product to menstruating people. Yeah.
46:40 Speaker 00 I can't wait. I can't wait to hear about this because I learned so much inadvertently about how little testing or standardization existed but prior to this.
46:49 Speaker 03 Oh, yeah. Oh, my God. I mean, did any? Yeah.
46:52 Speaker 00 Yeah.
46:53 Speaker 03 And so I really only knew the bare bones of this history before researching for this episode. And there is so much more to it. Like, like you said, I'm, I'm, I'm excited. Let's start at the beginning.
47:04 Speaker 00 Okay, okay.
47:05 Speaker 03 Okay, okay. September 25th, 1977.
47:09 Speaker 00 Okay.
47:09 Speaker 03 Denver, Colorado.
47:11 Speaker 00 Oh.
47:11 Speaker 03 I know. A girl 15 years old was rushed to the children's hospital, quote, "delirious and in shock after a two day history of worsening pharyngitis and vaginitis associated with vomiting and watery diarrhea." On admission, her temperature was 40.9 degrees Celsius, which is 105.6 degrees Fahrenheit.
47:31 Speaker 00 Oh, my gosh.
47:31 Speaker 03 And her blood pressure was 66 over zero.
47:36 Speaker 00 What?
47:38 Speaker 03 Yeah, that's what it said. I read it like eight times.
47:40 Speaker 00 Oh, my God.
47:41 Speaker 03 Yeah. She was described as having red, bloodshot eyes, a hugely swollen face and limbs, a red scaly rash covering her entire body, tender abdomen, purulent, I can't, I cannot say that word, Erin.
47:56 Speaker 00 It's a tough word.
47:57 Speaker 03 Okay, we know what I'm saying. Vaginal discharge and severe prolonged shock. She was described as quote unquote confused and aggressive, like no wonder, right?
48:08 Speaker 00 I'm sorry that you're gonna put the word aggressive in there.
48:11 Speaker 03 I know, I know. Confused and aggressive, right? But like, just putting yourself in her shoes, imagine how terrifying.
48:18 Speaker 00 Can you not just describe her as dying?
48:20 Speaker 03 Right, because like, she was acting a little aggressive.
48:23 Speaker 00 Oh, just a little aggressive.
48:26 Speaker 03 Her doctors pumped her full of IV fluids, antibiotics, steroids, heparin, digitalis, and put her on a ventilator. Unfortunately, after eight days of intensive care, she made a complete recovery.
48:38 Speaker 00 Wow.
48:38 Speaker 03 Except for some necrosis in a few of her toes, which ultimately had to be amputated.
48:43 Speaker 00 Okay.
48:43 Speaker 03 And the fact that her entire skin had started to slough off. But she was stable, and after 17 days in the hospital, she was discharged.
48:52 Speaker 00 My goodness, Anne.
48:54 Speaker 03 Yep. Her doctors were stumped. They had run tests for Rocky Mountain spotted fever, leptospirosis, scarlet fever, and other viral rash-causing diseases, but nothing had lit up. There was something familiar about this case, though, because over the previous couple of years, there had been a few more just like it in children aged eight to 17, seven total from 1975 to 1977, including one death.
49:23 Speaker 00 In Colorado or just like?
49:25 Speaker 03 In Colorado.
49:26 Speaker 00 Wow, okay.
49:26 Speaker 03 Yeah, that had written, like, I think, I don't know if it was like the hospital system or that hospital or like within the state, yeah.
49:32 Speaker 00 Yeah, okay.
49:34 Speaker 03 The doctors that had been working on these cases couldn't find anything that linked them. There was no food, no drug overdose, no exposure to an animal or a chemical, but the clinical picture was similar and resembled some of the syndromes caused by Staph aureus infections, like scalded skin syndrome and some staph food poisoning cases. Swab cultures confirmed that a toxin-producing staph aureus may be the culprit. And so, in combination with shock being a unifying feature of the syndrome, the Denver doctors named the new condition Toxic Shock Syndrome in a 1978 paper. Okay. Yeah. Was it actually new? Was this brand new? Probably not. I mean, probably not. Yeah. There were a few other cases that people found in
50:18 Speaker 03 the medical literature from as far back as the early 1900s. And there was some other, like, ancient plague that someone proposed. It doesn't really seem to track in my eyes. But one researcher suggested that it might be like a new toxin-producing strain. Okay. Sort of like how we talked about with scarlet fever. Again, strep pyogenes went from being like, super, super deadly to then not like, just massive shifts in- Shifts in what strains are there? The global strains, yeah. Yeah, yeah. And so regardless of whether this was new or not, the 1978 paper, which is by Todd et al., if you want to read it- Okay. -was a critical milestone for Toxic Shock Syndrome. Besides giving it a name, they also set out this clear clinical picture and described a general patient population.
51:03 Speaker 03 And so other physicians who happened to read this article began to connect the dots in their own patients, starting with physicians in Wisconsin, and then Minnesota, and then gaining enough momentum that the CDC got involved with what was rapidly becoming a public health crisis. The first morbidity and mortality weekly report on that featured Toxic Shock Syndrome was published in May 1980- Okay. -with these additional reported cases from these other states, researchers zeroed in on a toxin-producing strain of Staph aureus. Right? Like, that seemed to be behind it all. Behind these cases. Right? Right, right. But the root of transmission was still unclear.
51:45 Speaker 00 Mm hmm.
51:46 Speaker 03 The CDC initiated a study to find out how people were getting sick with this condition. And they identified about 50 women who had toxic shock syndrome and 50 women who did not, matched by sex, geographic area, age, and were often friends of the cases. So they were like, OK, what is different about these two individuals? Let's match them, these pairs.
52:06 Speaker 00 Love it, case control.
52:07 Speaker 03 There we go. And then using phone surveys, importantly, conducted by a woman, EIS Officer Catherine Shans, because I think that was a really crucial part of getting people to actually, these women, to feel like they could open up and talk about their experience.
52:21 Speaker 00 Yeah.
52:22 Speaker 03 They asked a million carefully worded questions about their lives, including menstruation and use of menstrual products. And a tentative pattern began to emerge. The people developing toxic shock syndrome were young, otherwise healthy women, who were menstruating at the time that symptoms developed and who used tampons. And I say tentative to describe the pattern because it wasn't really a smoking gun. There were plenty of tampon users who did not have toxic shock. But the devil, of course, would be in the details. Because tampons are not all created equal.
53:03 Speaker 03 Like, go to your local grocery store and check out the menstrual products aisle.
53:08 Speaker 00 If you haven't looked lately.
53:10 Speaker 03 Yeah. Shelves upon... I mean, I haven't looked lately because I haven't had a period in years now because the miracle of birth control pill for me. But it's shelves upon shelves of different brands, different absorbencies, different materials. I mean, the branding, the variety really is something else.
53:28 Speaker 00 The scents, Erin. I cannot.
53:31 Speaker 03 I mean, I cannot, yeah. And the landscape in the 19, the late 1970s, when toxic shock began popping up, was roughly similar to this. So why then? Like, what was happening in the late 1970s that led to suddenly the syndrome being recognized on a nation, on a, on a national scale?
53:51 Speaker 00 Tell me, Erin.
53:52 Speaker 03 Okay. Here's where we have to get into some tampon nuance.
53:55 Speaker 00 Yes.
53:57 Speaker 03 In the decade since the first commercially available tampon in 1936, just tampons, tampon technology had undergone some pretty big changes, very gradually at first, since the demand for tampons remained pretty low until the 1960s.
54:13 Speaker 00 Interesting.
54:13 Speaker 03 I mean, you, well, you couldn't advertise easily. So word of mouth was the main way that people learned about them. And then there was a great deal of hand wringing over how tampons were a threat to young women's purity and like, it's gonna ruin them, right? But eventually, though, the benefits that tampons provided, like being able to swim or dance or go on, you know, be in, work long shifts, all of these things won out over these anxieties. And by the 1960s, tampons were seen as a symbol of bodily freedom, of women's liberation. And as the consumer base for tampons grew, so did the companies making them. And slightly different versions of tampons appeared on the shelves, like each of them trying to edge out the competition, right? Like, they each have, oh, this one's
54:56 Speaker 03 slightly different. This one has a better name. This one has a better catchphrase. This one is more absorbent. This one is whatever. All these different things, applicator. The first tampons made were 100% cotton. But these newer tampons began to incorporate other fibers to increase absorbency, including synthetic fibers and materials developed in the mid 20th century. Things like polyester, viscose rayon, which is derived from wood cellulose and processed with other chemicals, polyacrylate, which you can also find as an absorbent in disposable baby diapers.
55:31 Speaker 00 Okay, that makes sense.
55:32 Speaker 03 Carboxymethyl cellulose, which comes from plant cellulose and shifts from powder to gel when introduced to liquids. And even today, it's next to impossible to find tampons made of 100% cotton alone. Like, very, very, very few do use those, or do use just cotton.
55:52 Speaker 03 Procter and Gamble's Rely tampon, which took, I know you, I know you know this.
55:56 Speaker 00 I can't wait to hear all about Rely.
55:58 Speaker 03 This is the tampon that took center stage in the toxic shock syndrome crisis of the 1980s. Rely was composed of, quote, "a polyester sheath, compressed polyurethane foam cubes, and carboxymethyl cellulose," end quote. And I just want to like, make a point here to say that just because chemical names of things are long and like sound complicated, does not mean that they are inherently bad.
56:28 Speaker 00 Right.
56:29 Speaker 03 But, the issue, and then I'll get into this a little bit more, is just like, the testing of this, right?
56:35 Speaker 00 Right.
56:36 Speaker 03 Because I feel very much like, oh, well, those don't sound like natural words. And it's like, that doesn't, right.
56:41 Speaker 00 Yeah, and it's also like, just because something is so-called natural, or is cotton rather than rayon, does also not mean that it is safer for you.
56:49 Speaker 03 Right.
56:50 Speaker 00 So something being a synthetic fiber does not make it inherently less, or inherently more dangerous.
56:56 Speaker 03 Across the board. I mean, maybe, maybe research will show that it, it does.
57:00 Speaker 00 Right.
57:01 Speaker 03 Maybe research will show that it does not, but, yeah. Yeah, we, just, the sweeping generalizations, I think, and just like, the idea that like, oh, that has a lot of big words.
57:10 Speaker 00 Yeah.
57:11 Speaker 03 Yes.
57:11 Speaker 00 Yeah.
57:13 Speaker 03 That being said.
57:14 Speaker 00 Yeah.
57:14 Speaker 03 Rely was, a big, yeah, a big part of this. So, uh, Rely was considered and advertised as a super-absorbent tampon with lightweight materials able to hold 50 to 1,500 times their weight in water.
57:28 Speaker 00 Wow.
57:29 Speaker 03 Yeah.
57:30 Speaker 00 Sounds like it'll dry you out real good.
57:32 Speaker 03 Oh, well, yeah, it did.
57:34 Speaker 00 I know.
57:34 Speaker 03 Yeah.
57:35 Speaker 00 That's a problem.
57:35 Speaker 03 That's a problem.
57:36 Speaker 00 Your vagina is supposed to be moist. Anyways, keep going.
57:40 Speaker 03 Anyways, so, with all of these new tampons coming onto the market, coming onto the grocery store shelves in the late 1970s, what was that approval process like?
57:53 Speaker 00 Tell me.
57:54 Speaker 03 To be honest, close to nonexistent.
57:56 Speaker 00 Yes, I knew it.
57:57 Speaker 03 I mean, yeah. Until 1976, tampons and sanitary pads were classified as cosmetics.
58:05 Speaker 00 Wow.
58:07 Speaker 03 Which, and so they were technically under the jurisdiction of the FDA. But there really wasn't any formalized review process for devices like those that were worn or implanted in the body or used to diagnose diseases.
58:20 Speaker 00 Wow.
58:21 Speaker 03 No official approval for these was necessary.
58:24 Speaker 00 Yeah.
58:25 Speaker 03 I mean, and this, this is a case, I think, of like, technology moving faster than our ability to like, understand the implications of it.
58:31 Speaker 00 Yeah, yeah.
58:32 Speaker 03 And over the 1970s, it became apparent that like, we need to do a better job. This was a mistake to not have any sort of official approval.
58:40 Speaker 00 Uh huh.
58:41 Speaker 03 Serious issues with pacemakers, IUDs, like the Dalcon Shield, lens implants, and other medical devices had left people with severe injuries and pursuing lawsuits. So in 1976, the Medical Device Amendments was added to the federal drug, the Federal Food Drug and Cosmetic Act. And it's worth getting a bit into the nitty gritty here because of the bearing that this would have on the emerging issue of toxic shock syndrome. So, under this amendment, devices were put into one of three categories based on their perceived risk. Class one was almost no risk, like bedpans, nitrile examination gloves, that sort of thing.
59:22 Speaker 03 Class two devices carried a bit more potential for risk, so like tampons and hearing aids, and required more testing, labeling, and monitoring. And then, there was class three. This was the riskiest bunch, like artificial hearts or other experimental devices. But, when this amendment was introduced, what do you do about the existing devices?
59:45 Speaker 00 Right.
59:45 Speaker 03 Like tampons, right? Most of these pre-amendment devices were just grandfathered into the system, and no disruption to sales or production happened. Any new tampons, I'm talking about tampons specifically here, could be ushered, uh, through this approval process pretty quickly if the company could demonstrate that they were quote unquote substantially equivalent to pre-amendment devices.
1:00:07 Speaker 00 That's a problem.
1:00:08 Speaker 03 It is a problem. And one of these substantially equivalent tampons was Procter & Gamble's Rely Tampon.
1:00:16 Speaker 00 Okay.
1:00:17 Speaker 03 Rely. It even absorbs the worry.
1:00:20 Speaker 00 Ay yi yi yi yi.
1:00:21 Speaker 03 This was the tagline on the sample box containing four Rely tampons that was shipped out en masse across the US to millions of homes from the mid 1970s to 1980. It's just like you get free tampons in the mail.
1:00:36 Speaker 00 Free tampons.
1:00:36 Speaker 03 Try it out. Maybe you'll like this. Super absorbent. The materials that were used in Rely tampons had been used in other tampons on the market. Just not the precise configuration.
1:00:49 Speaker 00 Right.
1:00:50 Speaker 03 But how could anyone know that?
1:00:53 Speaker 00 They cannot.
1:00:54 Speaker 03 Manufacturers are not required to disclose the exact composition of tampons, like materials, fragrances, et cetera, because it qualifies as a trade secret.
1:01:04 Speaker 00 Ay yi yi, the trade secret.
1:01:06 Speaker 03 The trade secrets. I mean, I have a lot of thoughts on that and some recent news about certain quote unquote, "unextinct" animals. Anyway.
1:01:16 Speaker 00 Oh, my gosh.
1:01:18 Speaker 03 We should do an episode.
1:01:19 Speaker 00 Dyer wolves?
1:01:20 Speaker 03 Dyer wolves. I mean, I can't say it without using quotes, but because. Anyway, overall, back to toxic shock.
1:01:31 Speaker 03 As far as I could tell, until the late 1970s, though, tampons had not been associated with any significant health issues or outbreaks since they had hit the shelves decades before. Like, it really doesn't seem to be like something. It was like more, maybe very sporadic types of, you know, individual issues, not outbreaks.
1:01:51 Speaker 00 Right.
1:01:52 Speaker 03 So the spate of toxic shock syndrome cases with the, beginning in the late 1970s, would reconfigure the perception of these devices as inert and completely benign. What had changed? That was the question that the CDC sought to answer. The June 27, 1980 MMWR described the link between toxic shock and tampons. Of the 105 cases since September 1978, 96% occurred in women aged 12 to 52 during their menstrual periods.
1:02:28 Speaker 00 Okay.
1:02:29 Speaker 03 96%.
1:02:30 Speaker 00 Yeah.
1:02:31 Speaker 03 And the case fatality rate was 15%.
1:02:32 Speaker 00 Wow, see, that's so high.
1:02:34 Speaker 03 So high. That's what I was asking and you were like, well, it's pretty low.
1:02:36 Speaker 00 Yeah.
1:02:37 Speaker 03 Like 15% is very high, yeah.
1:02:39 Speaker 00 And that's why I said, I don't know, all the numbers I saw, I think, were from current data.
1:02:44 Speaker 03 Right, right, right.
1:02:45 Speaker 00 So, yeah. Grains of salt.
1:02:47 Speaker 03 Exactly, yeah. In one case control study where they matched someone who had toxic shock with another person who didn't, like similar age, socioeconomic status, geographical location, et cetera, they found that 100% of the cases used tampons compared to 86% of the controls.
1:03:05 Speaker 00 Hmm.
1:03:06 Speaker 03 Vaginal cultures of those with toxic shock before starting antibiotics showed 94% positivity rate for staph aureus.
1:03:14 Speaker 00 Okay.
1:03:15 Speaker 03 And no similar cultures had been done for controls because like-
1:03:18 Speaker 00 Of course not.
1:03:19 Speaker 03 Yeah.
1:03:20 Speaker 00 Retrospective, yeah.
1:03:21 Speaker 03 Right, but in general, the prevalence of the bacterium in the vagina and cervix ranges from 2 to 15% is what I saw in this, in this book.
1:03:28 Speaker 00 Yeah, well, and because it depends too on, it can be up to 40% when it's just staph aureus, but not all of them are going to produce the toxins.
1:03:34 Speaker 03 Right, right, right.
1:03:35 Speaker 00 Very, very.
1:03:36 Speaker 03 Follow-up studies sought to get a handle on which tampons and why. And what they found is that across the board, tampons with higher absorbencies were associated with toxic shock syndrome. Several brands were implicated, but the clear winner, if you could call it that, I guess, was Reli.
1:03:54 Speaker 00 Reli.
1:03:55 Speaker 03 With 71% of those who had contracted toxic shock using the brand.
1:04:00 Speaker 00 Wow, I didn't realize it was that high.
1:04:02 Speaker 03 71.
1:04:03 Speaker 00 Well, yeah.
1:04:04 Speaker 03 And it's hard to say how much of it was Reli's popularity because it had become very popular over a very short time.
1:04:12 Speaker 00 Right.
1:04:13 Speaker 03 Especially with all those mail-out, you know, sample boxes.
1:04:15 Speaker 00 Yeah, like what percentage of those 86% of people who didn't get toxic shock also were using Reli tampons?
1:04:21 Speaker 03 26% of those in the control group used the brand.
1:04:24 Speaker 00 Okay, interesting.
1:04:25 Speaker 03 Yeah. But it wasn't just down to Rely's popularity.
1:04:28 Speaker 00 Right.
1:04:28 Speaker 03 The risks seemed to be higher for that specific tampon compared to other tampon brands. And researchers suspected that it had something to do with the composition of the tampon itself. So like I mentioned, all of the individual components of the Rely tampon had been used in other tampons previously, but not in combination.
1:04:47 Speaker 00 Right.
1:04:47 Speaker 03 And there seemed to be something specific about the blend of polyester and carboxymethylcellulose that encouraged bacterial growth. As you can imagine, this was not welcome news to Procter & Gamble, who were busy conducting their own studies that naturally were intended to cast doubt on what the CDC had found. They even tried to strong arm the CDC into giving them the names and contact information of the women who had been included in the first study.
1:05:13 Speaker 00 Excuse me?
1:05:15 Speaker 03 Yeah, because they were like, the CDC is inflating cases of toxic shock. Like, we don't think that these women actually had toxic shock, so we're going to have to go to their doctors and look in their medical records.
1:05:25 Speaker 00 Absolutely not!
1:05:27 Speaker 03 Yeah, the CDC was like, I'm sorry.
1:05:29 Speaker 00 No?
1:05:30 Speaker 03 What? No.
1:05:33 Speaker 03 So instead, the Procter & Gamble tracked down women who had called the company and complained that the tampons had made them sick, which like, there were a lot of complaints about Rely specifically. Their intention with tracking these women down was to try to undermine the CDC study.
1:05:50 Speaker 00 Oh my god.
1:05:51 Speaker 03 Saying that the cases of toxic shock they included weren't really toxic shock, and so Rely has, you know, nothing going on. This didn't work. And in response, then, they were like, well, we'll try something else. They were like, let's do this contradictory PR approach, where they touted Rely as, you know, these outstanding tampons, super unique, and they give you what no other tampon does. Also, at the same time, by being like, but like, Rely is just another tampon. It's not any different than these other tampons, or not any more dangerous than the other tampons out there. So it's like, they're saying Rely was-
1:06:24 Speaker 00 We're the best, we're so different, we're just like everyone else.
1:06:26 Speaker 03 We're just like everyone else. Exactly. Exactly. But at a certain point, they realized that there was nothing that could be done. And the CDC data was pretty damning. And so in September 1980, they realized the inevitable, and they tried to get ahead of like, the bad PR storm, and so they voluntarily pulled Rely from the shelves and issued a recall.
1:06:50 Speaker 00 I don't think I realized that it was a voluntary. So they didn't, they didn't actually get banned?
1:06:57 Speaker 03 No, it was a voluntary recall. And this included like print and television campaigns. And there's, I think that like, there's more to that story in terms of, like, I think that they saw the writing on the wall.
1:07:08 Speaker 00 Well, totally. But I just like, thought that they also actually got banned.
1:07:13 Speaker 03 No.
1:07:13 Speaker 00 Okay, cool.
1:07:14 Speaker 03 Well, and then, yeah, because this, there were implications to this. Right? Because on the one hand, this is great. This is what needed to happen. There was a clear association with Rely specifically and toxic shock syndrome. So this meant that this, you know, potentially dangerous product was no longer going to be available, available for purchase.
1:07:35 Speaker 00 Right.
1:07:36 Speaker 03 But on the other hand, this focus on Rely tampons only provided a false sense of security once they were removed from the shelves.
1:07:45 Speaker 00 Right.
1:07:46 Speaker 03 And it obscured the nuance in the relationship between tampons and toxic shock syndrome.
1:07:50 Speaker 00 Yes.
1:07:52 Speaker 03 It's hard to overstate the media frenzy surrounding toxic shock syndrome.
1:07:57 Speaker 00 Yeah.
1:07:57 Speaker 03 In 1980, it was the third leading news story in the nation, behind only the Iranian hostage situation and the presidential election.
1:08:07 Speaker 00 Wow.
1:08:08 Speaker 03 Toxic shock.
1:08:09 Speaker 00 Toxic shock.
1:08:10 Speaker 03 It was everywhere.
1:08:11 Speaker 00 Yeah.
1:08:11 Speaker 03 And this was overall, like, we talked about a good, a good thing in terms of raising awareness.
1:08:16 Speaker 00 Yeah.
1:08:16 Speaker 03 The CDC estimated that tampon use dropped from 70% to 55% by the end of 1980 because of toxic shock syndrome.
1:08:24 Speaker 00 Wow.
1:08:26 Speaker 03 But because the research was so new, misinformation was everywhere, with journalists and news anchors reporting all kinds of unsubstantiated hypotheses about the nature of this infection. Things like, Rely tampons cause toxic shock syndrome. Period. That's it. Toxic shock syndrome is a variant of scarlet fever. Tampons cause abrasions or ulcerations that serve as a route of entry for the bacterium. Tampons act as a plug that allows for bacterial growth. Leaving tampons in too long causes toxic shock. Removing tampons too soon causes Is toxic shock. I mean, like, just so many, there was no clear coherent message.
1:09:05 Speaker 00 Right.
1:09:06 Speaker 03 And part of it is, like, we discussed, because it is a very nuanced thing.
1:09:10 Speaker 00 Mm hmm.
1:09:11 Speaker 03 Um, but I think another part is because there was such fear and anxiety about, like, we need to solve this.
1:09:17 Speaker 00 Yeah.
1:09:17 Speaker 03 And so we need to report this as, like, we need to have a clear message to get out to the public. Rely tampons cause toxic shock.
1:09:24 Speaker 00 So that's the, that's the message they went with.
1:09:26 Speaker 03 Message, or tampons cause toxic shock.
1:09:29 Speaker 00 Yeah.
1:09:29 Speaker 03 Or taking them out too soon, you know, like, all of these different things.
1:09:33 Speaker 00 Yeah.
1:09:33 Speaker 03 And then you have some older male news anchors that refuse to say the words tampon or menstrual cycle on the air.
1:09:40 Speaker 00 So what did they say?
1:09:42 Speaker 03 They just didn't report on it, or they made somebody else do it.
1:09:45 Speaker 00 Right.
1:09:46 Speaker 03 Yeah. But the rest of them ran with the story. The mixed messaging and extensive airtime given to guesswork both contributed to the fears that surrounding toxic shock syndrome. I'm surprised I haven't stumbled more over toxic shock syndrome.
1:10:02 Speaker 00 You've been doing great.
1:10:03 Speaker 03 Hard thing to say over and over again.
1:10:05 Speaker 00 TSS.
1:10:05 Speaker 03 TSS. I might, maybe I'll switch to that.
1:10:07 Speaker 00 Yeah.
1:10:09 Speaker 03 But it, by also, so you're contributing to the fears and then also shifting blame to the consumer.
1:10:16 Speaker 00 Right. That's the thing, that's the thing, I think, Erin, and I think that that still happens today, even in the talk of, like, well, did, are you using the right absorbency?
1:10:23 Speaker 03 Are you using the right absorbency?
1:10:24 Speaker 00 Too long, blah, blah, blah. And I'm like, did you not buy the organic ones?
1:10:29 Speaker 03 Right.
1:10:30 Speaker 00 I'm sorry, what?
1:10:31 Speaker 03 Yeah.
1:10:32 Speaker 00 Yeah.
1:10:33 Speaker 03 Because the, that's the thing, is that the removal of Rely tampons didn't mean the removal of the threat of toxic shock syndrome.
1:10:42 Speaker 00 Yeah.
1:10:42 Speaker 03 And in fact, one report found that between January and September of 1980, which is when Rely was still on the market, 50 cases of TSS were reported in Minnesota, 45% associated with Rely. So it's 50 cases between that, those months. And in a similar period of time, after Rely had been pulled, there were 59 cases.
1:11:04 Speaker 00 Yeah.
1:11:04 Speaker 03 Mostly associated with other super absorbent tampon brands.
1:11:07 Speaker 00 Mm hmm.
1:11:08 Speaker 03 But now that there was no single brand to blame.
1:11:11 Speaker 00 Right, no scapegoat.
1:11:12 Speaker 03 No scapegoat, the responsibility to prevent the condition fell entirely to the consumer, with the logic following that if someone developed TSS, it was because they weren't using tampons properly.
1:11:24 Speaker 00 You didn't read the instructions.
1:11:25 Speaker 03 You didn't read the instructions. And on top of finally standardizing what junior, regular, super, and super plus actually meant, which happened in 1989.
1:11:34 Speaker 00 Erin, I want to do a whole episode on the tampon task force.
1:11:37 Speaker 03 Oh, yes, the tampon task force. Yes.
1:11:41 Speaker 00 And the singina. I learned so much.
1:11:43 Speaker 03 I know, I know. There is, I just, it seems like there was, it took so long to get anything.
1:11:51 Speaker 00 So long. It took so long. Like, it's unfathomable how it took so long and how then even after all that work, people are still like, yeah, I'm just gonna use saline still.
1:12:02 Speaker 03 Yes. I know. I know. I know. All of that. Yeah, there's, there's so much there.
1:12:08 Speaker 00 There's so much.
1:12:08 Speaker 03 I'll recommend a book at the end of this, but yeah. But, um, so yeah, they had standardized absorbencies. And then the FDA had also issued guidelines for warnings to be included on the tampon box or in an insert inside the box.
1:12:22 Speaker 00 Yeah.
1:12:23 Speaker 03 But the initial warnings were very vague. Attention, tampons are associated with toxic shock syndrome. TSS is a rare but serious disease that may cause death. Read and save the enclosed information.
1:12:36 Speaker 00 Wow.
1:12:37 Speaker 03 No detail on symptoms.
1:12:39 Speaker 00 No.
1:12:39 Speaker 03 So like, you're just like, there's this deadly disease.
1:12:42 Speaker 00 Right.
1:12:42 Speaker 03 We don't know what it looks like.
1:12:43 Speaker 00 Is it from the tampon?
1:12:45 Speaker 03 What do I look for?
1:12:46 Speaker 00 How do you know if I have it?
1:12:48 Speaker 03 Yeah, no information on how tampons were associated, even though at that point, it had been uncovered through research that it was likely that super absorbent tampons created, like you said, this more aerobic environment for staph aureus to multiply, and frequent changing created even more aerobic conditions.
1:13:05 Speaker 00 Oh, interesting.
1:13:06 Speaker 03 That's what some of the research said. But like you said, there's, it's nuanced, there's more.
1:13:10 Speaker 00 Yeah.
1:13:11 Speaker 03 More factors at play.
1:13:12 Speaker 00 Yeah.
1:13:13 Speaker 03 But even that messaging wasn't simple enough to be reported by major media outlets. And so the issue continued to be one of individual responsibility rather than consumer protection. Women were told to monitor their own bodies for signs of this deadly disease rather than manufacturers being forced to reevaluate their product and improve it to protect the health of their consumers if there was an association between whatever component, whatever material, and an increase in aerobic environment, or whatever it was.
1:13:46 Speaker 03 And yet, as Shara Vostrell, who's the author of Toxic Shock: A Social History, points out, which is the book that I read for this, things could have been much worse.
1:13:56 Speaker 00 Mm-hmm.
1:13:56 Speaker 03 If the toxic shock public health crisis had happened a year later, which would have been the first of the Reagan presidency, there wouldn't have been nearly as many women in the administration to advocate for women's health. Women like Dr. Catherine Shans, the EIS officer at the CDC during the time, who led the TSS task force.
1:14:17 Speaker 00 Wow.
1:14:18 Speaker 03 That could have led to decreased awareness, a slower change to manufacturing guidelines, and even less attention to the lack of transparency about tampon production. Since the height of the toxic shock syndrome crisis in the late 1970s and early 1980s, incidence has declined, thanks in large part to, from what I can tell, Rely being polled, materials like polyacrylate, polyester foam, and carboxymethylcellulose being discontinued in tampons, absorbency being standardized, and amazing advocacy and awareness work.
1:14:51 Speaker 00 Mm-hmm.
1:14:52 Speaker 03 Updated labeling requirements as of 2017 have boxes prominently display, quote, "Attention: Tampons are associated with toxic shock syndrome, TSS. TSS is a rare but serious disease that may cause death. Read and save the enclosed information. That enclosed information must include symptoms and estimates of incidence, advises to use minimum absorbencies, and declares that risk can be avoided altogether by not using tampons and alternating tampons with pads," which is not true.
1:15:25 Speaker 00 Risk can be avoided altogether?
1:15:27 Speaker 03 Apparently, that is what I read, yeah.
1:15:30 Speaker 00 Great.
1:15:31 Speaker 03 Yeah, that's what I read, that the enclosed information has to say.
1:15:33 Speaker 00 Okay.
1:15:34 Speaker 03 Despite the fact that it's been over 45 years since this story broke, there is still confusion, I feel, about tampons and toxic shock, about toxic shock overall, at both the scientific and consumer levels.
1:15:49 Speaker 00 Yeah.
1:15:49 Speaker 03 You know, how the two are related, how to reduce risk, and what safer alternatives exist. Can we make them? Do they exist?
1:15:57 Speaker 00 Mm-hmm.
1:15:57 Speaker 03 Given that more than 10% of women in the US are menstruating at any given time.
1:16:02 Speaker 00 Oh, I love that statistic.
1:16:03 Speaker 03 Yeah. This is not okay.
1:16:05 Speaker 00 Yeah.
1:16:06 Speaker 03 That we don't know the answers to these.
1:16:08 Speaker 00 Yeah.
1:16:09 Speaker 03 Research into women's reproductive health is continually underfunded and deprioritized. And the shame that surrounds menstruation keeps many women from talking about these issues or feeling like they are justified in demanding that things change. So Erin, tell me, are things changing? Do we know more stuff now?
1:16:31 Speaker 00 I'm not going to be able to answer that question, really.
1:16:37 Speaker 00 But I can tell you about what we do know.
1:16:41 Speaker 03 I love it.
1:16:42 Speaker 00 Okay.
1:16:44 Speaker 00 Right after this break.
1:17:11 Speaker 00 So let's just talk numbers for a quick second.
1:17:14 Speaker 03 Okay.
1:17:16 Speaker 00 This is, so toxic shock syndrome, staphylococcal and non-staphylococcal is a reportable disease in the US, and that's how they're classified. Staphylococcal, non-staphylococcal.
1:17:25 Speaker 03 Okay.
1:17:26 Speaker 00 Toxic shock. Since 1983, staphylococcal toxic shock has been notifiable. And since 1995, streptococcal toxic shock, or non-staphylococcal, has been notifiable. Global numbers, pretty much impossible for me to find.
1:17:42 Speaker 00 I don't have them. But this is, both of these diseases are quite rare. And the numbers in terms of the prevalence or the incidence each year really, really, really vary depending on what paper that I read. Most of them seem to come to the conclusion of around one-ish case per 100,000 people per year.
1:18:12 Speaker 03 Okay.
1:18:13 Speaker 00 But, but when I say they vary, I mean, like, there was a paper from 2018 that used UK Biobank data. And in Europe and the UK, these are not notifiable diseases. So the data is even more sparse. But looking at like Biobank data, they estimated an incidence of point zero seven cases of toxic shock per 100,000, which is really, really, really low.
1:18:35 Speaker 03 Huh.
1:18:36 Speaker 00 Um, yeah. Most of the US data estimates between point five and one per 100,000, though I've seen some that say up to two per 100,000 cases per year. When it comes to streptococcal, because most of that is for staphylococcal toxic shock, it's even more all over the place in terms of like what the numbers are, the estimates are. But it is estimated that some, somewhere in the range of like 10 to 20% of people who have an invasive group A strep infection will go on to develop toxic shock. And so estimates also range between like one and five per 100,000.
1:19:13 Speaker 03 Okay.
1:19:14 Speaker 00 But you'll be happy to know that because I was unsatisfied with all of the numbers that I was finding and because.
1:19:20 Speaker 03 Aaron math?
1:19:21 Speaker 00 Not quite Aaron. Yes, we're Aaron mathing.
1:19:23 Speaker 03 Okay, Aaronish math?
1:19:25 Speaker 00 Aaronish math. I went, this is a notifiable disease in the US. So if you didn't know this, you can go directly to the CDC where they have a national notifiable disease survey. And they have an interactive tool that can tell you that from, I know, me too, from 2016 to 2022. That's the most recent timeframe that they had. There were 2,144 cases of streptococcal toxic shock.
1:19:51 Speaker 03 Okay.
1:19:52 Speaker 00 And 217 cases of non-streptococcal or staphylococcal toxic shock that were reported.
1:19:58 Speaker 03 Interesting, the, the difference between, in magnitude between the two.
1:20:03 Speaker 00 Right. Streptococcal, I mean streptococcal infections are like quite still rampant. And so 10 to 20% of them are developing toxic shock.
1:20:10 Speaker 03 Yeah.
1:20:10 Speaker 00 So if we look then, if we Aaron math that a little bit, um, there's a range in years, but 145 to 416 cases per year was the range for streptococcal toxic shock in those different years. And then between 15 and 44 cases per year of staphylococcal toxic shock. In the whole entire US, that's what gets reported. And this is a reportable disease. So these numbers should be accurate in terms of what is identified.
1:20:39 Speaker 00 And so this is where we then have to remember that the like the case definitions that we use to identify these cases are imperfect, right? And so these are probably underestimates, even though they are accurate reported numbers, right?
1:21:00 Speaker 03 Yeah.
1:21:01 Speaker 00 Because these CDC criteria, and they do say this on the CDC website, they're like, you shouldn't use this as a clinical diagnosis. Like, this isn't what you should be using at the bedside to decide, am I calling this TSS or not? Because this is what we're using from a research perspective, and that's a little different, right?
1:21:15 Speaker 03 Interesting. Should they be different?
1:21:17 Speaker 00 I mean, they have to be in part because of this, the fact that like, the probable case definition, like, you can't, you can't do a full case definition without the one to two weeks later having this sloughing rash.
1:21:31 Speaker 03 I see.
1:21:32 Speaker 00 You're not gonna have that in the setting.
1:21:34 Speaker 03 Right, right, right.
1:21:35 Speaker 00 Right? So, yeah, so there, there is a little bit of variability there. And so these criteria will, will likely inevitably result in some degree of underreporting because of that. A lot of people are likely lost to follow up, and so you might not get the records on, did they end up developing a rash? Can we confirm that that's what that was or not? Right? Like, don't get me started on their lack of centralized medical records, so how can you go back and find that information? It's hard. Yeah, so we, the, it, the good news is, overall, it is very, very rare. Both staphylococcal, especially staphylococcal toxic shock, as well as streptococcal toxic
1:22:14 Speaker 00 shock are both rare diseases, likely underreported, but still very rare. And we talked already about the kind of mortality rates and things like that. Those haven't changed from the data that I found, in recent years at least. When it comes to the questions that you asked, Erin, about like, where are we going from here? What else have we learned?
1:22:38 Speaker 03 Yeah, what's, what's good? What change? What changes happened?
1:22:41 Speaker 00 I don't know, Erin, if we've come up with any changes since the tampon task force of the 1980s. Isn't that depressing?
1:22:50 Speaker 03 It is. It is.
1:22:53 Speaker 00 It's so depressing. And I, I, yeah, I, so I don't have any, I don't have any new news in terms of...
1:23:05 Speaker 00 What do we know about tampons and these relationships besides what we've talked about already? All of the, like across the board, the recommendations from CDC, from FDA, like based on all the epidemiological evidence that we have, and it's all epidemiological, and then there's some, you know, studies that have looked at like the composition of this tampon versus that tampon, is there a difference in lab settings of how much bacteria that you can grow and that kind of a thing?
1:23:34 Speaker 03 Yeah.
1:23:35 Speaker 00 Which are imperfect.
1:23:36 Speaker 03 Right, does that translate to human?
1:23:38 Speaker 00 Exactly. And like, who's funding those studies? I don't know. Most of what I saw did not suggest huge differences between the tampons that exist today, the tampons that are on the market today, regardless of their composition, in just in a laboratory setting, how much bacteria are they growing? Right? Which again, points to that it's not, it's not just the tampons themselves, it's this interaction between the tampons and the environment.
1:24:04 Speaker 03 Of course.
1:24:05 Speaker 00 The recommendations across the board are to use, like you said, the lowest absorbency that you can, which at least now they're standardized.
1:24:14 Speaker 03 I mean, I guess, yeah.
1:24:15 Speaker 00 To some degree.
1:24:16 Speaker 03 Still, how the heck do you, like, yeah, yeah.
1:24:18 Speaker 00 Yeah. Well, also because I always think, I used to think about this a lot when I used to use tampons. Like, what is six grams of menstrual blood? I don't know.
1:24:29 Speaker 03 No idea.
1:24:31 Speaker 00 No clue.
1:24:32 Speaker 03 It's just a little blue liquid, like.
1:24:34 Speaker 00 Oh, yes. That's what it is. That's what it looks like. So, yeah, but that is the recommendation, to change them at least every six to eight hours and not go longer than that. I didn't know that you weren't supposed to use them overnight, growing up, all the time.
1:24:49 Speaker 03 All the time.
1:24:50 Speaker 00 Did.
1:24:51 Speaker 03 Yeah.
1:24:52 Speaker 00 But, I mean, again, because this is so rare, like, I, I really like, Erin, the way that you went through all of the history of this and kind of emphasized the fact that, like, we need to hold accountable the correct groups, right? And it is not an individual's job to make sure that they don't get it.
1:25:15 Speaker 03 It's like, at the very least, I think that what it shows is just, and I know that there are people working on this, and I'm not saying that there's no one working on this, that there's no effort being, you know, no interest, no effort, no awareness. But like, the fact that we don't have some tools, maybe to be like, who is likely? Who has antibodies at high enough levels? What are the screening protocols? Like, how can we better get the message?
1:25:38 Speaker 00 How can we do better?
1:25:39 Speaker 03 Yes, how can we do better?
1:25:40 Speaker 00 Yes. Yeah, and I do think that that's an interesting arena, is like, and it's hard because of how rare it is, right? So like, where's the funding for it? Because people don't care as much. Where is the like, high kind of clinical suspicion to think, is there a test? Do I have a test that I can run? How do I run that test? On what population should I be running that test? When should I be thinking about it? When should I not? And those kinds of things. So it's all like, there needs to be a lot more done. I didn't find any updates on it. And maybe I missed it. So if you know of things, please let us know.
1:26:12 Speaker 03 Reach out, yeah.
1:26:14 Speaker 00 But if you want to know more.
1:26:16 Speaker 03 Ooh, sources.
1:26:18 Speaker 00 Papers and sources for you.
1:26:19 Speaker 03 Yeah, we do. I have some papers, but I would say, again, I'm just going to shout out that book Toxic Shocks, Toxic Shock: A Social History by Sharah Vostel.
1:26:31 Speaker 00 Love it.
1:26:32 Speaker 03 It's great.
1:26:33 Speaker 00 I had so many papers for this, Erin. Let me tell you some of my favorite ones, okay? From the Lancet 2019, or sorry, the Lancet Infectious Diseases 2019 by Berger et al., there was Menstrual Toxic Shock Syndrome Case Report and Systematic Review of the Literature. Such an interesting case report in there, too. Really highlights how much we don't know and how we likely underdiagnose it. There was a really very thick book that I read just one chapter of called The Paul Grave Handbook of Critical Menstruation Studies. And the chapter was called Toxic Shock Syndrome and Tampons: The Birth of a Movement and a Research Agenda. So that was an interesting, really liked it.
1:27:13 Speaker 03 Love that.
1:27:13 Speaker 00 But I also want to shout, I had a bunch more, like, you know, research papers and things, but I also wanted to give a shout out to a Washington Post article from 2016 by someone, so last name was Cowart, because I didn't write their first name, that was called Women Are Still Getting Toxic Shock Syndrome and No One Quite Knows Why. It just is a really, it's kind of like this podcast, but in written form. It was a really great overview. They went into the history, they went into like, way more detail on the biology than I see in a lot of, you know.
1:27:43 Speaker 03 Popular media.
1:27:44 Speaker 00 Yeah. So it was a really great, like, very overview of it. So I wanted to give that one a shout out. But we have so many more sources on our website, thispodcastwillkillyou.com, all of them from this episode and every one of our episodes.
1:27:59 Speaker 03 Thank you so much again to Autumn for sharing your story with us. We appreciate it. Just more than we can say.
1:28:06 Speaker 00 It really does mean so much to us. So thank you. Thank you also to Bload Mobile, who provides the music for this episode and every single one of our episodes.
1:28:15 Speaker 03 Thank you to Tom and Leanna and Pete and Brent and everyone else who at Exactly Right, who does so much to help us with this podcast.
1:28:23 Speaker 00 We really love it. It's fun. Thank you to you for listening and watching.
1:28:31 Speaker 00 I'm embarrassed by that face.
1:28:32 Speaker 03 I liked it. I liked it.
1:28:35 Speaker 00 Thank you so much for being with us through this. I hope you liked this episode.
1:28:38 Speaker 03 Yeah. Yeah. Let us know. Let us know what else you want to hear. And as always, a special thank you to our patrons. We appreciate your support so very much.
1:28:48 Speaker 00 Yes. Thank you.
1:28:50 Speaker 03 Well, until next time, wash your hands.
1:28:53 Speaker 00 You filthy animals.
1:29:23 Speaker 04 This is Shirley Strawberry from the Steve Harvey Morning Show. Buy smart, drive for less, and trade for more. That's Toyota affordability. And it starts with a great deal on an all-wheel-drive Camry, Corolla Cross, or a Corolla Sedan with the latest features and tech. Or test drive a spacious Grand Highlander or adventure-ready RAV4. And with so many hybrid models available, you can enjoy longer trips without all the stops. While Toyota's legendary Sell value means you could get more at trade in, get a great deal today and a great value tomorrow. Shop toyota.com for deals and details. Toyota, let's go places. With ChatGPT, you can do more than get answers.
1:30:07 Speaker 04 You can get things done. Whether you're leading a big project, planning an elaborate trip, or trying to balance work and life, ChatGPT can help. Give it a goal, plus things like files, notes, or project plans,
1:30:19 Speaker 02 develop a trip itinerary with daily updates, or create a priority schedule. So you can spend less energy sorting out the details and more on bringing your biggest ideas to life. Get started at chatgpt.com.
1:30:33 Speaker 02 Hey, I'm Niall Rogers. This fall, I'll be driving across the country, meeting some of today's coolest and most fascinating artists. We'll explore the stories before the moments that changed everything. Because every musician remembers the moment where it all began. Experience Before the Moment. A Lincoln Original Series on the iHeart Radio app, YouTube, or wherever you get your podcasts.
Previous Ep 176 Strychnine: The WD-40 of Victorian Medicine Next Special Episode: Dr. Wendy Kline & Exposed Page updated November 3, 2026 · transcript and summary are machine-generated